<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11559">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02956460</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-73</org_study_id>
    <nct_id>NCT02956460</nct_id>
  </id_info>
  <brief_title>Performance Comparison Between Fanfilcon A and Senofilcon C Sphere Lenses</brief_title>
  <official_title>Performance Comparison Between Fanfilcon A and Senofilcon C Sphere Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1
      month dispensing study (2 weeks each lens pair)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to determine the clinical performance of fanfilcon A in comparison
      to senofilcon C sphere contact lenses.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective assessment for comfort is assessed. Scale 0-10, 0=painful, 10=can't feel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dryness</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings for dryness is assessed on a scale of 0-10, 0=extremely dry, 10=no dryness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vision quality</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings of vision quality is assessed on a scale 0-10, 0=not sharp/not clear, 10=sharp/clear</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens handling</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings of lens handling - insertion and removal - is assessed using scale 0-10, 0=difficult to handle, 10=very easy to handle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vision satisfaction</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings of vision satisfaction is assessed on a scale 0-10, 0=completely dissatisfied, 10=completely satisfied.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens centration</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Lens centration will be recorded by degree and direction in the primary position. (Optimum, decentration acceptable, decentration unacceptable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival staining</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Assessed using slit lamp with blue light and sodium fluorescein, low medium magnification.
0=None, no staining present
Very slight
Slight
Moderate
Severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoothness</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings for lens sensation of smoothness is assessed on a scale 0-10, 0=not smooth at all, 10=totally smooth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clean feeling</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings for lens clean feeling is assessed on a scale 0-10, 0=not clean at all, 10=lenses feel perfectly clean</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens hydrated</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings for lens sensation is assessed on a scale 0-10, 0=totally dehydrated, 10=totally hydrated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens wettability</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Subjective ratings for lens wettability is assessed on a scale 0-10, 0=non-wettable, 10=highly wettable</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>fanfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants are randomized to wear fanfilcon A for two weeks during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants are randomized to wear senofilcon C for two weeks during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fanfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>fanfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon C</intervention_name>
    <description>contact lens</description>
    <arm_group_label>senofilcon C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          -  Is between 18 and 40 years of age (inclusive)

          -  Has read, understood and signed the information consent letter

          -  Has had a self-reported eye exam in the last two years

          -  Is a spherical soft contact lens wearer

          -  Has a contact lens prescription that fits within the available parameters of the
             study lenses

          -  Has a spectacle cylinder no greater than 0.75D (Diopters) in each eye

          -  Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or
             better in each eye

          -  Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye
             with the study contact lenses

          -  Has clear corneas and no active ocular disease

          -  Is willing and anticipated to be able to comply with the wear schedule (8 hours per
             day; 5 days a week of lens wear)

          -  Is willing and able to follow instructions and maintain the appointment schedule

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Has a history of not achieving comfortable CL (Contact Lens) wear (defined as 5 days
             per week; &gt;8 hours/day)

          -  Is currently wearing senofilcon C (2 weeks lens), senofilcon A 1-Day, senofilcon C
             (monthly lens) or enfilcon A contact lenses

          -  Is habitually using rewetting/ lubricating eye drops more than once per day

          -  Presents with clinically significant anterior segment abnormalities

          -  Presents with ocular or systemic disease or need of medications which might interfere
             with contact lens wear

          -  Presents with slit lamp findings that would contraindicate contact lens wear such as:

               -  Pathological dry eye or associated findings

               -  Significant pterygium, pinguecula, or corneal scars within the visual axis

               -  Neovascularization &gt; 0.75 mm in from of the limbus

               -  Giant papillary conjunctivitis (GCP) worse than grade 1

               -  Anterior uveitis or iritis (or history in past year)

               -  Seborrheic eczema of eyelid region, Seborrheic conjunctivitis

               -  History of corneal ulcers or fungal infections

               -  Poor personal hygiene

          -  Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

          -  Has aphakia, keratoconus or a highly irregular cornea

          -  Has presbyopia or has dependence on spectacles for near work over the contact lenses

          -  Has undergone corneal refractive surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyndon Jones, PhD, FAAO</last_name>
    <role>Study Director</role>
    <affiliation>Centre for Contact Lens Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eric M. White O. D., Inc</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Vision</name>
      <address>
        <city>Sarsota</city>
        <state>Florida</state>
        <zip>34232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nittany Eye Associates</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 7, 2017</lastchanged_date>
  <firstreceived_date>November 3, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
